San Diego Flavor Ban: Savior or Sabotage?

Jun.20.2022
San Diego Flavor Ban: Savior or Sabotage?
San Diego bans flavored e-cigarettes and tobacco, except for premium cigars, shisha and FDA-approved cessation devices. Experts debate effectiveness.

The SAAFE Act, proposed by Representative Marni von Wilpert, would ban flavored electronic cigarettes and tobacco products, but exempts high-quality flavored cigars, flavored loose-leaf tobacco, and hookah.

 

Flavorless or tobacco-flavored electronic cigarettes, as well as FDA-approved smoking cessation devices, are also unrestricted.

 

Last week, Mayor Todd Gloria signed the ban into law.

 

Marni von Wilpert, a legislator, stated that "This new law will save lives and protect the health of children.

 

Our new partnership with the San Diego School will provide parents with important health resources, and as such, we are taking every possible step to prevent big tobacco from luring our children and hijacking their future.

 

Is a flavor ban the answer?

 

Meanwhile, renowned cardiologist and smoking cessation researcher Dr. Konstantinos Farsalinos has recently reiterated that vape flavors are crucial in helping smokers switch to safer nicotine alternatives.

 

A researcher recently published a paper titled "The Spice of Life: A Case for Mitigating Tobacco Harms to Save Lives," which examines in detail the relationship between flavored nicotine products and successful smoking cessation.

 

The report emphasizes that flavor bans are a form of prohibition that only fuels the growth of a large black market, and leads to an increase in smoking rates as many e-cigarette users will revert back to smoking.

 

In a recent regulatory review, Farsalinos discussed a report examining the proposed ban by the Canadian Department of Health. He suggested that the reasons for implementing such a ban may be weakening, as evidence continues to emerge of its potential negative impact on public health.

 

Source: VapingPost

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Japan to Raise Heated Tobacco Prices From April; BAT Japan Keeps Prices Unchanged for 38 glo Tobacco Stick Products
Japan to Raise Heated Tobacco Prices From April; BAT Japan Keeps Prices Unchanged for 38 glo Tobacco Stick Products
Japan will implement price increases centered on heated tobacco products from April 1, 2026, following a tobacco tax hike. BAT Japan has decided to keep current prices unchanged for 38 glo-compatible tobacco stick products across the Velo, neo, Lucky Strike, and Kent lines.
Mar.30 by 2FIRSTS.ai
STMA Issues Trial Credit Management Rules for E-Cigarette Manufacturers and Wholesalers
STMA Issues Trial Credit Management Rules for E-Cigarette Manufacturers and Wholesalers
Mar.26 by 2FIRSTS.ai
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands released a trading update on April 14, reiterating its FY26 guidance and saying its 2030 transformation has started positively. The company said it still expects low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% growth in Group adjusted operating profit, at least high-single-digit earnings per share growth, and at least GBP 2.2 billion in free cash flow for the full year.
Apr.14 by 2FIRSTS.ai